Neurodegenerative Diseases

Retromer Therapeutics is developing novel therapeutics to treat neurodegenerative diseases.
Pre-clinical

OVERVIEW:

Retromer Therapeutics is a pre-clinical stage biotech company pioneering a new class of therapeutics to treat neurodegenerative diseases by resorting the function of the endolysosmal trafficking system with preclinical programs in neurodegenerative disorders including Alzheimer’s disease.

Type 1 diabetes
Metrics:

In the United States, as many as 6.2 M people may have Alzheimer’s disease.

Occur when nerve cells in the brain or peripheral nervous system lose function over time and ultimately die.

Sources:
Medline, National Institute of Environmental Health Science, Alzheimer’s Disease Association, Parkinson’s Foundation

REASONS
TO BELIEVE

INVESTOR INQUIRIES

CAREER INQUIRIES

GENERAL INQUIRIES